NYSE:AGN - New York Stock Exchange, Inc. -
193.02
+0.03 (+0.02%)
The current stock price of AGN is 193.02 null. In the past month the price increased by 5.94%. In the past year, price increased by 37.71%.
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Allergan Plc
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK
DUBLIN L2 D17 E400
CEO: Brenton L. Saunders
Phone: 862-261-7000
The current stock price of AGN is 193.02 null. The price increased by 0.02% in the last trading session.
The exchange symbol of Allergan Plc is AGN and it is listed on the New York Stock Exchange, Inc. exchange.
AGN stock is listed on the New York Stock Exchange, Inc. exchange.
Allergan Plc (AGN) has a market capitalization of 63.50B null. This makes AGN a Large Cap stock.
Allergan Plc (AGN) has a support level at 190.33 and a resistance level at 200.16. Check the full technical report for a detailed analysis of AGN support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
Allergan Plc (AGN) has a dividend yield of 1.53%. The yearly dividend amount is currently 2.96. Check the full fundamental report for a detailed analysis of AGN dividend history, reliability and sustainability.
The PE ratio for Allergan Plc (AGN) is 10.94. This is based on the reported non-GAAP earnings per share of 17.64 and the current share price of 193.02 null. Check the full fundamental report for a full analysis of the valuation metrics for AGN.
ChartMill assigns a technical rating of 9 / 10 to AGN. When comparing the yearly performance of all stocks, AGN is one of the better performing stocks in the market, outperforming 92.42% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to AGN. While AGN is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months AGN reported a non-GAAP Earnings per Share(EPS) of 17.64. The EPS increased by 5.69% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -15.44% | ||
ROA | -2.81% | ||
ROE | N/A | ||
Debt/Equity | 0.31 |
ChartMill assigns a Buy % Consensus number of 63% to AGN. The Buy consensus is the average rating of analysts ratings from 15 analysts.